Endoscopic Treatment of Esophageal Varices: Endoscopic Variceal Ligation Using a Multi-Band Ligator

  • Yoshiyuki SuzukiEmail author
  • Naoya Murashima


Endoscopic variceal ligation (EVL), a safe and effective treatment for esophageal varices, has undergone rapid progress since its invention. One of the greatest advantages of EVL over endoscopic injection sclerotherapy (EIS) is its versatile adaptability, particularly for high-risk populations such as elderly patients. Originally, the “Stiegmann-Goff Ligator Kit” (Bard Co., USA) used for the EVL procedure was equipped with a wire to remove the ligature bands from the endoscope. In Japan, the modified pneumo-activated EVL device (Sumitomo Bakelite Co. Ltd.) was invented and came into common use. These single-band ligators require an over-tube to ligate esophageal varices. However, we now use a multi-band ligator without an over-tube to perform ligations in rapid succession. This chapter contains an outline description of the multi-band ligator comparing with the single-band ligator.


  1. 1.
    Fukui H, Saito H, Ueno Y, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51:629–50.CrossRefGoogle Scholar
  2. 2.
    D’Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology. 2004;39:30–4.CrossRefGoogle Scholar
  3. 3.
    Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–38.CrossRefGoogle Scholar
  4. 4.
    Feu F, García-Pagán JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–9.CrossRefGoogle Scholar
  5. 5.
    D’Amico G, Garcia-Pagan JC, Luca A, et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611–24.CrossRefGoogle Scholar
  6. 6.
    Burroughs AK, Triantos CK. Predicting failure to control bleeding and mortality in acute variceal bleeding. J Hepatol. 2008;48:185–8.CrossRefGoogle Scholar
  7. 7.
    Ideo G, Bellati G, Fesce E, et al. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology. 1988;8:6–9.CrossRefGoogle Scholar
  8. 8.
    Garden OJ, Mills PR, Birnie GG, et al. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. Gastroenterology. 1990;98:185–90.CrossRefGoogle Scholar
  9. 9.
    Schepke M, Kleber G, Nurnberg D, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65–72.CrossRefGoogle Scholar
  10. 10.
    Stiegmann GV, Goff JS, Michaletz Onody PA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992;326:1527–32.CrossRefGoogle Scholar
  11. 11.
    Gimson AES, Ramage JK, Panos MZ, et al. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices. Lancet. 1993;342:391–4.CrossRefGoogle Scholar
  12. 12.
    Laine L, El-Newihi HM, Migikovsky B, et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993;119:1–7.CrossRefGoogle Scholar
  13. 13.
    Hou MC, Lin HC, Kuo BIT, et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology. 1995;21:1517–22.PubMedGoogle Scholar
  14. 14.
    Sarin SK, Govil A, Jain AK, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol. 1997;26:826–32.CrossRefGoogle Scholar
  15. 15.
    Baroncini D, Milandri GL, Borione D, et al. A prospective randomized trial of sclerotherapy versus ligation in the treatment of bleeding esophageal varices. Endoscopy. 1997;29:235–40.CrossRefGoogle Scholar
  16. 16.
    Takeuchi M, Nakai Y, Sha S, et al. Combined ligation and paravariceal injection sclerotherapy for esophageal varices: outcome over 3 years. Gastroenterol Endosc. 1997;39:1189–95.Google Scholar
  17. 17.
    Jia Y, Dwivedi A, Elhanafi S, et al. Low risk of bacteremia after endoscopic variceal therapy for esophageal varices: a systematic review and meta-analysis. Endosc Int Open. 2015;03(05):409–17.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of HepatologyToranomon HospitalTokyoJapan
  2. 2.Department of GastroenterologyMishuku HospitalTokyoJapan

Personalised recommendations